Abstract
Caffeine is a widely used compound found both in drug preparations and in commonly consumed foods and beverages. Most human exposure occurs primarily through consumption of caffeinated beverages (e.g., coffee, tea, and soft drinks) such that, across all age groups, the average daily dose of caffeine ranges from <1 mg/kg in infants to approx 3 mg/kg in adults, including pregnant women (Lachance, 1982; Neims and von Borstel, 1983; Sobotka, 1989; Benowitz, 1990). Because caffeine is a pharmacologically and behaviorally active chemical, exposure of the developing organism to caffeine may have far-reaching, long-term consequences. Such developmental exposure may occur in utero as the result of consumption of caffeine by the pregnant woman or postnatally as the result of therapeutically administered caffeine to premature infants with apnea of prematurity. This chapter will deal with animal models for such perinatal caffeine exposure. In order to facilitate extrapolation of results from experimental animals to humans, the factors that must be taken into account in the design and interpretation of these studies will be presented. The neurochemical mechanisms whereby caffeine exposure may affect subsequent neural development and behavior/function will also be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aranda J. V. and Turmen T. (1979) Methylxanthines in apnea of prematurity. Clin. Perinatol. 6, 87–108.
Aranda J. V., Cook C. E., Gorman W., Collinge J. M., Loughnan P. M., Outerbridge E. W., Aldridge A., and Neims A. H. (1979) Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J. Pediatr. 94, 663–668.
Barrington W. W., Jacobson K. A., Hutchison A. J., Williams M., and Stiles G. L. (1989) Identification of the A2 adenosine receptor binding sub-unit by photoaffinity crosslinking. Proc. Natl. Acad. Sci. 86, 6572–6576.
Benowitz N. L. (1990) Clinical pharmacology of caffeine. Ann. Reu. Med. 41, 277–288.
Boer G. J., Feenstra M. G. P., Mirmiran M., Swaab D. F., VanHaanen F., Chen-Pelt W., and Eikelboom T. (1988) Neurochemistry of Functional Neuroteratology: Permanent Effects of Chemicals on the Developing Brain. Elsevier, Amsterdam.
Bonati M., Latini R., Galletti F., Young J. F., Tognoni G., and Garattini S. (1982) Caffeine disposition after oral doses. Clin. Phamacol. Ther. 32, 98–106.
Boulenger J. P., Patel R. M., Parma A. M., and Marangos P. J. (1983) Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci. 32, 1135–1142.
Bruns R. F. (1988) Adenosine receptor assays, in Adenosine Receptors (Dermot M. F. and Cooper C. L., eds.), A. R. Liss, New York, pp. 41–62.
Bruns R. F., Daly J. W., and Snyder S. H. (1980) Adenosine receptors in brain membranes: Binding of N6-cyclohexyl[3H]adenosien and 1,3-diethyl-8-[3H]phenylxanthine. Pm. Nutl. Acad. Sci. USA 77, 5547–5551.
Bruns R. F., Katims J. J., Annau Z., Snyder S. H., and Daly J. W. (1983) Adenosine receptor interactions and anxiolytics. NeuropharrnacoIogy 22, 1523–1529.
Bruns R. F., Lu G. H. and Pugsley T. A. (1986) Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol. Pharmacol 29, 331–346.
Burg A. W. and Werner E. (1972) Tissue distribution of caffeine and its metabolites in the mouse. Biochem. Phamcol. 21, 923–936.
Butcher R. E., Vorhees C. V., and Wootten V. (1984) Behavioral and physical development of rats chronically exposed to caffeinated fluids. Fund. Appl. Toxicol. 4, 1–13.
Chasnoff I. J. (1991) Cocaine and pregnancy: Clinical and methodologic issues. Clin. Perinatol. 18, 113–124.
Choi 0. H., Shamim M. T., Padgett W. L., and Daly J. W. (1988) Caffeine and theophylline analogues: Correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci. 43, 387–398.
Concannon J. T., Braughler J. M., and Schechter M. D. (1983) Pre-and post-natal effects of caffeine on brain biogenic amines, cyclic nucleotides and behavior in developing rats. J. PhmnacoZ. Exp. Ther. 226, 673–679.
Coyle J. T. (1977) Biochemical aspects of neurotransmission in the developing brain. Int. Rev. Neurobiol. 20, 65–103.
Coyle J. T. and Henry D. (1973) Catecholamines in fetal and newborn rat brain. J. Neurochem. 18, 2061–2075.
Daly J. W. (1985) Adenosine receptors, in Advunces in CycZic Nucleotide and Protein Phosphorylation Research vol. 19 (Cooper D. M. F. and Seamon K. B., eds.) Raven Press, New York, pp. 29–46.
Daly J. W., Bruns R. F., and Snyder S. H. (1981) Adenosine receptors in the central nervous system: Relationship to the central actions of methylxanthines. Life Sci. 28, 2083–2097.
Deckert J., Morgan P. F., and Marangos P. J. (1988) Adenosine uptake site heterogeneity in the mammalian CNS? Uptake inhibitors as probes and potential neuropharmaceuticals. Life Sci. 42, 1331–1345.
Dobbing J. (1979) Prenatal nutrition and neurological development, in Early Malnutrition and Mental Development (Cravido J., Hambraeus L., and Vahlquist B., eds.) Almquist and Wiksell, Stockholm, pp. 96–110.
Driscoll P. G., Joseph F., Jr., and Nakamoto T. (1990) Prenatal effects of maternal caffeine intake and dietary high protein on mandibular development in fetal rats. Br.J. Nutrition 63, 285–292.
Dunlop M. and Court J. M. (1981) Effects of maternal caffeine ingestion on neonatal growth in rats. Biol. Neonate 39, 178–184.
Dunwiddie T. V. (1985) The physiological role of adenosine in the central nervous system. lnt. Rev. Neurobiol. 27, 63–139.
Enslen M., Milon H., and Wurzner H. P. (1980) Brain catecholamines and sleep states in offspring of caffeine-treated rats. Experientia 36, 1105–1106.
Etzel B. A. and Guillet R. (1990) The ontogeny of adenosine A1 receptors in rat brain using receptor autoradiography. Sot. Neurosci. Abstr. 16, 697.
Fredholm B. B. (1982) Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol. Scund. 115, 283–286.
Fuglsang G., Nielsen K., Nielsen L. K., Sennes F., Jakobsen P., and Thelle T. (1989) The effects of caffeine compared with theophylline in the treatment of idiopathic apnea in premature infants. Actu Paediatr. Scand. 78, 786–788.
Fuller G. N. and Wiggins R. C. (1981) A possible effect of the methybcanthines caffeine, theophylline and aminophylline on postnatal myelination of the rat brain. Brain Res. 213, 476–480.
Fuller G. N., Divakaran P., and Wiggins R. C. (1982) The effect of postnatal caffeine administration on brain myelination. Bruin Res. 249, 189–191.
Gilbert E. F. and Pistey W. R. (1973) Effect on the offspring of repeated caffeine administration to pregnant rats. J. Reprod. Fert. 34, 495–499.
Gilbert S. G., Stavric B., Klassen R. D., and Rice D. C. (1985) The fate of chronically consumed caffeine in the monkey (Macaca fascicularis). Fund. Appl. Toxicol. 5, 578–587.
Goldberg M. R., Curatolo P. W., Tung C.-S., and Robertson D. (1982) Caffeine down-regulates β adrenoreceptors in rat forebrain. Neurosci. Left. 31, 47–52.
Green R. M. and Stiles G. L.(1986) Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex. J. Clin. Invest. 77, 222–227.
Guillet R. (1990a) Neonatal caffeine exposure alters adenosine A1 receptor kinetics during a critical developmental period. Sot. Neurosci. Abstr. 16, 66.
Guillet R. (1990b) Neonatal caffeine exposure alters adenosine receptor control of locomotor activity in the developing rat. Dev. Phurmacol. Ther. 15, 94–100.
Guillet R. and Kellogg C. K. (1991) Neonatal exposure to therapeutic caffeine alters the ontogeny of adenosine A1 receptors in brain of rats. Neuropharmacol. 30, 489–496.
Guillet R. and Kellogg C. K. (1991) Neonatal caffeine exposure alters develpmental sensitivity to adenosine receptor ligands. Pharmacol.Biochem. Behav. 40, 811–817.
Gunn T. R., Metrakos K., Riley P., Willis D., and Aranda J. V. (1979) Sequelae of caffeine treatment in preterm infants with apnea. J. Pediatr. 94, 106–109.
Hawkins M., Dugich M. M., Porter N. M., Urbanic M., and Radulovacke M.(1988) Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain. Brain Res. Bull. 21, 479–482.
Holloway W. R. (1982) Caffeine: Effects of acute and chronic exposure on the behavior of neonatal rats. Neurobehuv. ToxicoI Teratol. 4, 21–32.
Holloway W. R., Jr. and Thor D. H. (1982) Caffeine sensitivity in the neonatal rat. Neurobehav. Toxicol. Teratol. 4, 331–333.
Hughes R. N. and Beveridge I. J. (1990) Sex-and age-dependent effects of prenatal exposure to caffeine on open-field behavior,emergence latency and adrenal weights in rats. Life Sci. 47, 2075–2088.
Italian Collaborative Group on Preterm Delivery (1988) Early neonatal drug utilization in preterm newborns in neonatal intensive care units. Dev. Pharmacol. Ther. 11, 1–7.
Jarvis M. F. (1988) Autoradiographic localization and characterization of brain adenosine receptor subtypes, in Receptor Localization: Ligand Autoradiography, Alan R. Liss, Inc., New York, pp. 95–111.
Jarvis M. F. and Williams M. (1988) Differences in adenosine A-1 and A-2 receptor density revealed by autoradiography in methylxanthine-sensitive and insensitive mice. Phmcol. Biochem. Behav. 30, 707–714.
Jarvis M. F., Schulz R., Hutchison A. J., Do U. H., Sills M. A. and Williams M. (1989) [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251, 888–893.
Kaplan G. B., Tai N. T., Greenblatt D. J., and Shader R. I. (1990) Caffeine-induced behavioural stimulation is dose-and concentration-dependent. Br.1. Pharmacol. 100, 435–440.
Kaplan G. B., Greenblatt D. J., Leduc B. W., Thompson M. L. and Shader R. I. (1989) Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity. J. Phartnacol. Exp. Ther. 248, 1078–1083.
Kellogg C. K., Primus R. J., and Bitran D. (1991) Sexually dimorphic influence of prenatal exposure to diazepam on behavioral responses to environmental challenge and on γ-aminobutyric acid (GABA)-stimulated uptake in the brain. J. Pharmacol. Exp. Ther. 256, 259–265.
Khanna K. L., Rao G. S., and Comish H. H. (1972) Metabolism of caffeine-3H in the rat. Toxicol. Appl. Pharmacol. 23, 720–730.
Kirch D. G., Taylor T. R., Gerhardt G. A., Benowitz N. L., Stephen C., and Wyatt R. J. (1990) Effect of chronic caffeine administration on monoamine and monoamine metabolite concentrations in rat brain. Neuropharmacology 29, 599–602.
Lachance M. P. (1982) The pharmacology and toxicology of caffeine. J. Food Safety 4, 71–112.
Langley J. N. (1906) On nerve-endings and on special excitable substances in cells. Proc. R. Sot. Lond. (Biol.) 78, 170–194.
Latini R., Bonati M., Marzi E., Tacconi M. T., Sadurska B., and Bizzi A. (1980) Caffeine disposition and effects in young and one-year-old rats. J.Pharm. Pharmacol. 32, 596–599.
Latini R., Bonati M., Castelli D., and Garattini S. (1978) Dose-dependent kinetics of caffeine in rats. Toxicol. Lett. 2, 267–270.
Lauder J. M. and Krebs H. (1986) Do neurotransmitters, neurohumors, and hormones specify critical periods? in Developmental Neuropsychobiology(Greenough W. T. and Junaska J. M., eds.), Academic Press, New York, pp. 119–174.
Lawrence R. A. (1980) Breastfeeding: A Guide for the Medical Profession. Mosby,St. Louis.
Lee K. S. and Reddington M. (1986) Autoradiographic evidence for multiple CNS binding sites for adenosine derivatives. Neurosci. 19, 535–549.
Le Guennec J. C., Sitruk F., Breault G., and Black R. (1990) Somatic growth in infants receiving prolonged caffeine therapy. Acta Pediatr Scand 79, 52–56.
Lupica C. R., Jarvis M. F., and Berman R.F. Chronic theophylline treatment in vivo increases high affinity adenosine A1 receptor binding and sensitivity to exogenous adenosine in the in vitro hippocampal slice. Brain Res. (in press).
Lupica C. R., Cass W. A., Zahniser N. R., and Dunwiddie T. V. (1990) Effects of the selective adensoine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J. Phmnacol. Exp. Ther. 252, 1134–1141.
Marangos P. J., Boulenger J.-P. and Patel J. (1984) Effects of chronic caffeine on brain adenosine receptors: Regional and ontogenetic studies. LifeSci. 34, 899–907.
Marangos P. J., Patel J., and Stivers J. (1982) Ontogeny of adenosine binding sites in rat forebrain and cerebellum. J. Nezmchem. 39, 267–270.
Marangos P. J., Patel J., Martino A. M., Dilli M., and Boulenger J. P. (1983) Differential binding properties of adenosine receptor agonists and antagonists in brain. J. Neurochem. 41, 367–374.
Miller R. K., Kellogg C. K., and Saltzman R. A. (1987) Reproductive and perinatal toxicology, in Fundamentals of Toxicology (Bemdt W. 0. and Haley W., eds.), Hemisphere Pub. Corp., Washington, DC, pp. 159–309.
Miranda R., Ceckler T., Guillet R., and Kellogg C. K. (1990a) Early developmental exposure to benzodiazepine ligands alters brain 31P NMR spectra in young adult rats. Brain Res. 506, 85–92.
Miranda R., Ceckler T., Guillet R., and Kellogg C. K. (1990b) Aging-related changes in brain metabolism are altered by early developmental exposure to diazepam. Neurobiol. Aging 11, 117–122.
Mori M., Wilber J. F., and Nakamoto T. (1983) Influences of maternal caffeine on the neonatal rat brains vary with the nutritional states. Life Sci. 33, 2091–2095.
Mori M., Wilber J. F., and Nakamoto T. (1984) Protein-energy malnutrition during pregnancy alters caffeine’s effect on brain tissue of neonate rats. Life Sci. 35, 2553–2560.
Nakamoto T. and Shaye R. (1986) Protein-energy malnutrition in rats during pregnancy modifies the effects of caffeine in fetal bones. J. Nutr. 116, 633–640.
Nakamoto T., Hartman A.D., and Joseph F., Jr. (1989) Interaction between caffeine intake and nutritional status on growing brains in newborn rats. Ann. Nutrition Metab. 33, 92–99.
Nakazawa K., Tanaka H., and Arima M. (1985) The effect of caffeine ingestion on pharmacokinetics of caffeine and its metabolites after a single administration in pregnant rats. J Pharmacobio.-Dyn. 8, 151–160.
Nau H. (1986) Species differences in pharmacokinetics and drug teratogenesis. Env. Health Perspectives 70, 113–129.
Neims A. H. and von Borstel R. W. (1983) Caffeine: Metabolism and biochemical mechanisms of action, in Nutrition and the Bruin, vol. 6 (Wurtman R. J. and Wurtman J. J., eds.), Raven, New York, pp. 1–30.
Parkinson F. E. and Fredholm B. B. (1990) Autoradiographic evidence for G-protein coupled A2-receptors in rat neostriatum using [3H]-CGS 21680 as a ligand. Naunyn-Schmiedeberg’s Arch. Pharmacol. 342, 85–89.
Quinby G. E. Jr. and Nakamoto T. (1984) Theophylline effects on cellular response in proteinenergy malnourished neonatal rat brain. Pediatr.Res. 18, 546–549.
Quinby G. E., Batirbaygil Y., Hartman, A. D., and Nakamoto T. (1985)Effects of orally administered caffeine on cellular response in protein energy-malnourished neonatal rat brain. Pediatr. Res. 19, 71–74.
Ramkumar V., Bumgarner J. R., Jacobson K. A., and Stiles G. L. (1988) Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion. J.Clin. Invest. 82, 242–247.
Resnick O. and Morgan P. J. (1983) Animal models for small-for-gestational-age (SGA) neonates and infants-at-risk. Devel. Bruin Res. 10, 221–225.
Schneider P. E., Miller H. I., and Nakamoto T. (1990) Effects of caffeine intake during gestation and lactation on bones of young growing rats. Res. Exp. Med. 190, 131–136.
Simmons R. D., Kellogg C. K., and Miller R. K. (1984a) Prenatal diazepam exposure in rats: long-lasting, receptor-mediated effects on hypothalamic norepinephrine-containing neurons. Brain Res. 293, 73–83.
Simmons R. D., Miller R. K., and Kellogg C. K. (1984b) Prenatal exposure to diazepam alters central and peripheral responses to stress in adult rat offspring. Brain Res. 307, 39–46.
Siiton C. M. (1989) Preliminary indications that functional effects of fetal caffeine exposure can be expressed in a second generation. Neurotoxicol.Teratol. 11, 357–362.
Slob A. K., Snow C. E., and de Natris-Mathot E. (1973) Absence of behavioral deficits following undernutrition in the rat. Dev. Psychobiol. 6, 177–186.
Smart J. L., Billing A. E., Duggan J. P., and Massey R. F. (1989) Effects of early life undernutrition in artificially-reared rats: 3. Further studies of growth and behavior. Physiol. Behav. 45, 1153–1160.
Smart J. L. (1990) Vulnerability of developing brain to undernutrition. Upsala Med. Sci. Suppl. 48, 21–41.
Snyder S. H. and Sklar P. (1984) Behavioral and molecular actions of caffeine:Focus on adenosine. J. Psychiatr. Res. 18, 91–106.
Snyder S. H., Katims J. J., Annau Z., Bruns R. F., and Daly J. W. (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc.Natl. Acad. Sci. USA 78, 3260–3264.
Sobotka T. J. (1989) Neurobehavioral effects of prenatal caffeine, in Prenatal Abuse of Licit and Illicit Drugs (Hutchings D. E., ed.), Ann. NY Acad.Sci. vol. 562, NY Acad. Sci., New York, pp. 327–339.
Sobotka T. J., Spaid S. L., and Brodie R. E. (1979) Neurobehavioral teratology of caffeine exposure in rats. Neurotoxicol. 1, 403–416.
Soyka L. F. (1979) Effects of methylxanthines on the fetus. Clin. Perinutol. 6, 37–51.
Stavric B. and Gilbert S. G. (1990) Caffeine metabolism: A problem in extrapolating results from animal studies to humans. Acta Pharm. Jugosl. 40, 475–489.
Swenson R. R., Beckwith B. E., Lamberty K. J., and Krebs S. J. (1990) Prenatal exposure to AVP or caffeine but not oxytocin alters learning in female rats. Peptides 11, 927–932.
Tanaka H., Nakazawa K., and Arima M. (1987) Effects of maternal caffeine ingestion on the perinatal cerebrum. Biol. Neonate 51, 332–339.
vanCalker D., Muller M., and Hamprecht B. (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J, Neurochem. 33, 999–1005.
Wan W., Sutherland G. R., and Geiger J. D. (1990) Binding of the adenosine A2 receptor ligand [3H]CGS 21680 to human and rat brain: Evidence for multiple affiity sites. J. Newochem. 55, 1763–1771.
West G. L., Sobotka T. J., Brodie R. E., Beier J. M., and O’Donnell M. W., Jr.(1986) Postnatal neurobehavioral development in rats exposed in utero to caffeine. Neurobehav. Toxicol. Teratol. 8, 29–43.
Yazdani M., Hartman A. D., Miller H. I., Temples T. E., and Nakamoto T.(1988) Chronic caffeine intake alters the composition of various parts of the brain in young growing rats. Dev. Pharmacol. Ther. 11, 102–108.
Zielke C. L. and Zielke H. R. (1987) Chronic exposure to subcutaneously implanted methylxanthines: Differential elevation of A1-adenosine receptors in mouse cerebellar and cerebral cortical membranes. Biochem.Pharmacol. 36, 2533–2538.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 The Humana Press Inc.
About this protocol
Cite this protocol
Guillet, R. (1992). Animal Models for Caffeine Exposure in the Perinatal Period. In: Boulton, A.A., Baker, G.B., Wu, P.H. (eds) Animal Models of Drug Addiction. Neuromethods, vol 24. Humana Press. https://doi.org/10.1385/0-89603-217-5:383
Download citation
DOI: https://doi.org/10.1385/0-89603-217-5:383
Publisher Name: Humana Press
Print ISBN: 978-0-89603-217-0
Online ISBN: 978-1-59259-629-4
eBook Packages: Springer Protocols